KirstenMarieWilliamsMD

Pediatric Hematology & Oncology • Atlanta, GA

Associate Professor of Pediatrics Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Emory University

Join to view full profile

Dr. Williams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Williams' full profile

Already have an account?

Office
1405 Clifton Rd NE
Atlanta, GA 30322
Phone+1 404-785-1112

Fax+1 404-785-6288

Summary

Dr. Kirsten Williams is a pediatric hematologist/oncologist in Atlanta, GA and is affiliated with Children's National Health System. She received her medical degree from Georgetown University School of Medicine and has been in practice 17 years. She is experienced in pediatric bone marrow transplantation and immunocompromised host.

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2003 - 2006
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2000 - 2003
Georgetown University School of MedicineClass of 2000

Certifications & Licensure

GA State Medical License 2019 - 2025
DC State Medical License 2009 - 2020
MD State Medical License 2003 - 2019
OH State Medical License 2000 - 2003
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Montelukast to Treat Bronchiolitis Obliterans Start of enrollment: 2008 Jun 17
Completed
Phase 2
Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation Start of enrollment: 2011 Apr 19
Completed
Phase 2
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies Start of enrollment: 2015 Jan 01
Recruiting
Phase 1
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT Start of enrollment: 2021 Feb 05
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation.
Jennifer Holter-Chakrabarty, Lacey McNally, John Levine, James Ferrara, Sara K Vesely
Radiology. Imaging Cancer. 2025-01-01
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transpla...
Neel S Bhatt, Andrew C Harris, Lev Gorfinkel, Katarzyna Ibanez, Eric R Tkaczyk
Transplantation and Cellular Therapy. 2024-12-17
Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency.
Erin L Frost, Satheesh Chonat, Kirsten M Williams, Waitman Aumann, Jason Stevenson
British Journal of Haematology. 2024-12-08

Press Mentions

Netcare Teams Go Above and Beyond to Vaccinate Mentally Challenged Home with KindnessJuly 18th, 2021
Agent Can Reveal HSC Engraftment FasterMarch 5th, 2018
Helpful, Hopeful News for Bone Marrow Transplant PatientsFebruary 28th, 2018
Join now to see all

Grant Support

Initiation of a novel immunotherapeutic to safely eradicate acute leukemiaLeukemia Lymphoma SocietyPresent
Imaging and Blood Biomarkers to predict graft failureNIH/ NHLBI R01Present